Savara, Inc. (SVRA)
4.81
-0.24
(-4.66%)
USD |
NASDAQ |
Oct 02, 16:00
4.815
0.00 (0.00%)
After-Hours: 20:00
Savara Net Income (Quarterly) : -40.23M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -40.23M |
| March 31, 2026 | -37.28M |
| December 31, 2025 | -32.24M |
| September 30, 2025 | -29.56M |
| June 30, 2025 | -30.40M |
| March 31, 2025 | -26.64M |
| December 31, 2024 | -29.04M |
| September 30, 2024 | -24.25M |
| June 30, 2024 | -22.24M |
| March 31, 2024 | -20.35M |
| December 31, 2023 | -16.10M |
| September 30, 2023 | -16.60M |
| June 30, 2023 | -11.44M |
| March 31, 2023 | -10.56M |
| December 31, 2022 | -10.30M |
| September 30, 2022 | -10.39M |
| June 30, 2022 | -9.164M |
| March 31, 2022 | -8.30M |
| December 31, 2021 | -11.31M |
| September 30, 2021 | -10.55M |
| June 30, 2021 | -10.94M |
| March 31, 2021 | -10.22M |
| December 31, 2020 | -13.74M |
| September 30, 2020 | -11.06M |
| June 30, 2020 | -9.389M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.42M |
| December 31, 2019 | -31.72M |
| September 30, 2019 | -12.40M |
| June 30, 2019 | -21.94M |
| March 31, 2019 | -12.11M |
| December 31, 2018 | -10.51M |
| September 30, 2018 | -12.56M |
| June 30, 2018 | -11.59M |
| March 31, 2018 | -26.85M |
| December 31, 2017 | -6.502M |
| September 30, 2017 | -6.817M |
| June 30, 2017 | -11.50M |
| March 31, 2017 | -4.974M |
| December 31, 2016 | -3.968M |
| September 30, 2016 | -3.227M |
| June 30, 2016 | -2.051M |
| March 31, 2016 | -11.21M |
| December 31, 2015 | -10.16M |
| September 30, 2015 | -9.912M |
| June 30, 2015 | -10.15M |
| March 31, 2015 | -9.616M |
| December 31, 2014 | -7.313M |
| September 30, 2014 | -7.866M |
| June 30, 2014 | -7.152M |
| March 31, 2014 | -6.371M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -10.50B |
| Insmed, Inc. | -13.24M |
| United Therapeutics Corp. | 333.00M |
| Vertex Pharmaceuticals, Inc. | 1.100B |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 40.23M |
| EPS Diluted (Quarterly) | -0.1587 |
| Enterprise Value | 845.34M |
| Earnings Yield | -11.99% |
| Normalized Earnings Yield | -11.99 |